⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of GPW Group and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
GPW Group
↗Saarbrücken, Germany
GPW Group is an international pharmaceutical wholesaler headquartered in Germany and the Netherlands. The company specializes in the sourcing, distribution, and placement of unlicensed, hard-to-find, and shortage medicines, bridging critical care gaps for patients and healthcare providers globally.
Operating through three dedicated business units—GPW Germany, GPW International, and Orly Pharma—the group leverages over 60 years of combined expertise to manage the regulatory, legal, and logistical complexities of named-patient supply and comparator drug sourcing for clinical trials.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Pharmaceutical Distribution & Named Patient Supply
SIZE & FINANCIALS
Employees:51-200
Founded:1963
Ownership:private
Status:operating
FUNDING
Investors:Silver Investment Partners (SIP)
0
CORPORATE STRUCTURE
Subsidiaries:GPW Germany (formerly Jüers Pharma), GPW International (formerly Lucien Ortscheit), Orly Pharma
Key Partnerships:Manufacturers, license holders, and distributors globally for named-patient supply and clinical trial sourcing.
COMPETITION
Position:Niche Player
Competitors:Clinigen, Other specialized pharmaceutical wholesalers
LEADERSHIP
Key Executives:
Nick Rhys-Jones - CEO
LINKS
Website:gpw-group.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with GPW Group. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.